Table 4.
Cardiac and pulmonary imaging findings in 37 children with multisystem inflammatory syndrome associated with coronavirus disease 2019 (COVID-19)
| Cardiac/pulmonary findings | Radiography | Echocardiography | CT | Cardiac MRI |
|---|---|---|---|---|
| Study frequency | 36/37 (97%) | 35/37 (95%) | 12/37 (32%) | 12/37 (32%) |
| Cardiac findings | ||||
| Cardiomegaly | 20/36 (56%) | 1/12 (8%) | 1/12 (8%) | |
| Pulmonary congestion/oedema | 27/36 (75%) | 8/12 (67%) | ||
| Impaired ventricular function | 16/35 (46%) | 3/12 (25%) | ||
| Atrioventricular valve insufficiency | 4/35 (11%) | |||
| Increased central venous pressure | 3/35 (9%) | |||
| Pericardial effusion | 6/35 (17%) | 4/12 (33%) | 5/12 (42%) | |
| Coronary artery abnormality | 5/35 (14%) | 1/12 (8%) | ||
| Myocardial oedema | 7/12 (58%) | |||
| Lung findings | ||||
| Increased, ill-defined central broncho-vascular markingsa | 22/36 (61%) | 5/12 (42%) | ||
| Peripheral reticular pattern/septal thickening | 7/36 (19%) | 9/12 (75%) | ||
| Ground-glass opacity | 9/36 (25%) | 10/12 (83%) | ||
| Airspace opacity/consolidation | 10/36 (28%) | 7/12 (58%) | ||
| Pleural effusion | 6/36 (17%) | 7/12 (58%) | ||
| Nodular consolidation on CT | 1/12 (8%) | |||
aIncludes bronchial wall thickening, peribronchial cuffing